LUNB:VIE
H Lundbeck A/S Class B
€6.02
arrow_downward
-0.58%(-0.035) 1D
Sep 28, 5:36:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LUNB...
Open
€6.06
High
€6.06
Low
€6.01
Mkt. cap
44.75B
Avg. vol.
62.00
Volume
0.00
52-wk high
€6.40
52-wk low
€4.85
No. of employees
5K
Open
€6.06
High
€6.06
Low
€6.01
Mkt. cap
44.75B
Avg. vol.
62.00
Volume
0.00
52-wk high
€6.40
52-wk low
€4.85
No. of employees
5K
News stories
From web sources and news partners
The Business Journals
·
4 hours ago
Lundbeck to shutter Chicago-area headquarters
Crain's Chicago Business
·
3 days ago
Illinois biopharma loses another HQ as Danish drugmaker leaves Deerfield for Boston
Fierce Pharma
·
3 days ago
Lundbeck to move US digs to Boston as it eyes bigger innovation frontiers
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class B
CEOCharl Van Zyl
Employees5K
FoundedAug 14, 1915
Headquarters-
SectorPharmaceutical industry
Websitelundbeck.com